Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
Hehe ;)
Oh ye of little faith. The wonderful Synairgen zealots see the share price temporarily move up and automatically believe that they are out of the woods.
As I wrote last week and wrote this week, LET THE GAMES BEGIN :)
I was correct with 12p when I called it, then correct with 10p and correct with 7p. Let’s wait and see what happens, my 4p target price still stands and I stand by it.
Now let’s trade this turkey. Adios zealots.
Tommy, be quiet you child.
Two possibilities, either you are obviously irate because the realisation that you have lost all that money you invested at 24p has finally sunk in and come home to roost.
Or, you, along with brand, dunk, aether and fruits are still constantly trying to ramp this steaming trash can and becoming very frustrated because whoever is paying you to continue the hype is getting angry with you.
This company is sheer trash. Almost 14 months after their spectacular failure in which they single handedly destroyed their reputation and any future they might have had, they have been totally silent.
They have nothing, they know that.
Either you are incredibly naive, or paid to ramp garbage. Either way, be quiet now. If you were a real investor you would be angry that your shares are worth 8p and soon will be worth 4p.
Good morning. This mornings readings shows that Synairgen is down to 8.4p, a solid 97% loss since last February. My target price well and truly reached.
Given that the company clearly has no ability to fund their own trials at any stage of development, nor seems willing to fund a trial, solely reliant on handouts (which are not there). Could we see the end of any potential commercial activity for this company at all?
They have x amount of money to keep them going, Marsden must be close to retirement now surely after milking this cow for the last twenty years. If they keep hold of their money without funding any new trials they could see out another couple of years on full salaries and then the BOD could retire nicely?
It was a shot in the dark during covid for a university spin off, but the game is well and truly over now. Back to being a university research project after Marsden retires comfortably.
Seems to be a common theme these days, I set a target price, followed by legendary Synairgen zealots explaining how I am wrong and that Synairgen are going to the moon, it’s only a matter of time.
They are all wrong, once again the target price is reached.
Repeat over again.
New target price is historic low 4p
(Watch how they all attack, just like they attack mr Costs)
The one person they never criticise is Marsden, their hopeless, overpaid CEO who has had 20 years of failure behind him and can’t even come out to say anything.
The latest ramp is that Marsden was talking about Australia winter time and not English winter time. Hahahahahaha :-D
They get more and more desperate every time.
What a pile of steaming turd. 4p price target.
Continuing from certain rampers on this forum who are trying to make out that Paxlovid has less potential utility than previously thought.
Synairgen’s single unapproved drug is zero competition for Paxlovid.
The reason for this is simple. Synairgen doesn’t even have its failed drug on a trial, let alone waiting to be FDA approved.
Paxlovid is already FDA approved and is used all over the world.
It will take multiple years (minimum) for Synairgen’s drug to be approved, if it ever gets approved, the market knows this, hence the abysmal share price. There will need to be fund raises in this time and share dilution.
By the time (if they finally get it over the line) Synairgen’s drug is approved, the patent for Paxlovid will be long expired anyway and generic companies will be selling Paxlovid for a far cheaper price than Pfizer currently sells it at.
It wreaks of desperation when the big ramp of the day is that the Conservative government might be helping Synairgen.
How bad is the outlook of a company if the rampers big ramp of the day is that their government could help by giving money?
This translates to
Synairgen have no commercial drug and no trial, no money to fund a trial and no plan to go commercial. They have exhausted COPD and Covid, failed at both, failed in 20 years of attempts and now are reliant on their government for cash handouts to survive.
The fund raise is coming at the end of the year whether you or any other blind Synairgen fanatical zealot has their fingers in their ears and their blinkers on.
There is nothing you or any other zealot can do to stop a fund raise when the cash runway ends, otherwise the company goes bust.
No amount of ramping could prevent what happened to the share price after the phase 3 calamity occurred. So too, no amount of ramping can stop a fund raise from happening.
To all blinkered Synairgen zealots with your fingers in your ears chanting to yourself ‘Marsden will bring success, Marsden will bring success, Marsden will bring success’, you have been told loud and clear:
AT THE END OF THR YEAR THE CASH RUNWAY ENDS, the fund raise will dilute your shares even more and your wealth will decline in half again.
Paladin (an aptly named screen name for such a legendary zealot).
You might not agree with me but you have been wrong every single time, as have the other Synairgen zealots.
You can defend your CEO as much as you like, but he’s been utter garbage, hence why your shares are now worth sub 10p.
What people do you agree with?
You seem to agree with people who mentioned:
Bill Gates
Johnson and Johnson
STRIVE
Deep dive data
Free trial from big pharma
Buy out
SPAC merger
The people you agree with were wrong every single time. Yet every single time I set a target price it is reached.
You KNOW THAT THE CASH RUNWAY ENDS at the end of the year. You know that when a cash runway ends, the company will have no funds left. Yet you are somehow saying that the company will not need a fund raise, despite having no funds left at the end of the year?
Essentially, even though you know logic and truth, you are saying that logic and truth will not happen?
You are siding with people who are always wrong and having a proven track record of being wrong, yet disagreeing with logic and truth at the same time.
Just because you disagree, it does not mean the fund raise and share dilution is not coming.
Get ready for the fund raise at the end of the year when the cash runway ends.
Possibility Synairgen could receive a grant instead of having to do a fund raise at the end of the year when their cash runway ends? The grant would only be a few million, not enough for a trial or their increasing expenses for long.
Very small hope. Similar to the hope of being thrown a free trial, akin to big pharma feeling generous to throw the little dog begging for food a bone. Except big pharma are business, they would only do this if feeling extremely charitable (or tax break implications). Especially to a company that needs to start from scratch again with its single unapproved asset.
Drew x
Good morning to genuine readers. Whilst some of the bewildered and rightly disappointed investors on here are considering what to ask the board at the next AGM. As well as the steady band of merry legendary Synairgen zealots who are defending the CEO at all costs and still ramping the company, here are two dimes of thought.
Perhaps Marsden will announce the fund raise at the next AGM?
There is a possibility of this (a higher possibility of this announcement coming at the AGM than the announcement of a free trial, free trials don’t simply get handed out no matter how hard one begs).
We know that a fund raise will be needed at the end of the year when the cash runway ends, but we haven’t heard when the next AGM will be. Perhaps this is because Marsden will be announcing the next fund raise for the company then and issuing more shares?
Daneeka, you clearly are incredibly stupid.
You said that you know who you would pay if you were polygon.
Hehe it’s laughable. POLYGON ARE NOT BUYING ANYMORE. Haven’t you noticed they stopped buying a while ago?
This is how delusional you and your merry men of legendary zealots are. You mention Polygon as if they would be hiring people to lower the share price so they can buy more cheap shares, yet you can clearly see that Polygon haven’t bought any shares in a long time. In fact Polygon are losing even more money every day. What kind of backwards Trumpian logic are you using?
So blinkered, so foolish and so naive.
This turd is a sinking ship. Even when you lose everything you won’t utter a curse at Marsden, you will gladly submit your wealth and curse those people who told you the truth a year ago.
Legendary Synairgen zealots who have seen their wealth diminish by 98% and still they utter ‘he’s trying to buy your cheap shares’.
If I wanted to buy some shares I would buy some shares at 9p. If polygon wanted more they would buy at 9p. You are utterly delusional, wake up you little fat nugget and smell the coffee.
The irony that the one who is called ‘banal connective tissue’ by fanatical Synairgen zealots who have been consistently wrong for the last year and seen their wealth decline by 97%, has been correct far more times than them.
Remember these words loud and clear:
Synairgen are going to have a fund raise when the cash runs out and then your shares will be diluted even more. When that happens I will be here to gloat and I already know your pathetic response. You will relish the thought of submitting your wealth entirely to Marsden and even when the fundraise comes and your shares are worthless, you will hound at me, whilst you still post up little irrelevant studies in to interferons trying to ramp this turd and deflect from Marsden.
What happened over the last year:
.Takeover?
. JV?
. Bill Gates?
. SPAC merger?
. Platform trial?
.STRIVE?
You are wrong on every single account.
You doubled down on this turd when it was in the 20’s and now you have lost 60% of your new investment.
Feel free to treble down at this share price, you’ll lose a further 60% in a couple of months time anyway.
Remember, no matter how hard you try to ramp, you can not polish a turd.
As Pfizer braces for less income from its covid related drugs, due to the market for covid drugs shrinking now that the pandemic is over, it seeks more revenue streams.
https://www.reuters.com/markets/deals/pfizer-buy-seagen-deal-valued-43-billion-2023-03-13/
Seagen have four approved drugs and multiple therapies in current clinical trials already.
An excellent example of a biotech company that is being bought out by big pharma.
Synairgen have one unapproved drug which has failed it’s phase 3 trial and don’t have a single drug on any trial. To suggest they are worthy of a takeover is beyond Trumpian stupidity.
Aether, you are posting links about mental illness, about being psychotic. LOOK AT YOURSELF.
You are the one that has been consistently wrong with regards to Synairgen.
You are the one saying I have been ‘tracked’.
What kind of disgusting zealotry is this? Tracking other people from an internet forum?
Then you have the audacity to say that I am psychotic?
You are a mega zealot. You live, breathe and love Marsden. You love to submit your wealth to Synairgen and you will protect Marsden at all costs, you love it.
Meanwhile I have been correct with all my price predictions and have been correct with regards to calling out the zealots.
The hilarity of someone talking about ‘tracking’ others down, then calling them ‘psychotic’.
You are a fanatical psychotic Synairgen mega zealot.
You will only be happy once you have submit all your wealth to Marsden.
I did call it indeed.
But there is no need to rub salt in to wounds.
The sensible investor will avoid this company for now, but be ready to invest after the fund raise is announced and share dilution is inevitable.
Fund raise is coming, that is inevitable now.
If Synairgen do manage to get on a free trial somehow (STRIVE is a minor chance, although a JV is even lower chance than STRIVE) then it gives more confidence in the company. But the fund raise will itself lead to share dilution and lowering of share price.
Therefore the sensible approach is to wait to see if that rate scenario where Synairgen can be placed on a free trial occurs. Then WAIT for the fund raise, then buy in to the company after the fund raise when share dilution occurs.
Drew.
Good morning people, lovely sunny day today.
Today we see the SP fall in to the 9p range.
As predicted the downward slide continues and we will see further downward movement, at least towards 8p.
Mrcosts gave an excellent summary of the clinical and business prowess of the Synairgen CEO Marsden in the last year.
‘’RM leads a failed phase 3 trial.??RM then fails to find a new trial and misses his own new deadline to be on a trial’’
We have been told that the company has enough cash runway to last until the end of this year. But if we start piecing together timelines, the picture that gets painted is not good.
When the funding for the last P3 trial was secured, it took the company over six months to begin their trial, this was during a pandemic and working on full cylinders at haste. Therefore it would be naive to believe Synairgen could work at any faster levels in the future.
So if we take the best scenario, let’s say Synairgen are announced to be on STRIVE (unlikely, but a possibility).
This announcement comes in August when the share price is 7 to 8p and the price enjoys a nice spike. The trial design will be done by the NIH, it will take at least 3 months for Synairgen to gather materials, possible in vitro tests required prior to commencing a new P3 trial at the very earliest possible date of November 2023.
Even in the small chance of Synairgen being selected to be on STRIVE, they will still require a fund raise when their cash runway runs out at the end of this year.
So the fundraise and share dilution is now inevitable.
As an outsider currently, it makes much more sense to wait until the inevitable fund raise before buying in to this company.
The fund raise is coming at the end of the year. Marsden knows this. His only mission is to secure a free trial so that he can then dangle the carrot to future potential investors who would invest at the next fund raise. Without a free trial he knows that Synairgen will not be able to secure future funding and the company will go bust.
Huge gamble, with a relatively low chance of getting selected on to a free trial.
Better to wait and see if they are invited on to a free trial first, then wait until the end of the year for the fund raise, investing after the fund raise when the share price has fallen due to the dilution.
Drew.
Good afternoon everyone. Congrats on getting a 10% rise in SP for anyone trading this share. Time to cash out and take the gain
Given that Synairgen will run out of cash at the end of 2023, if no funding or joint trial is announced before then, the share price will drop further due to considerable necessary dilution in order to keep the company afloat.
Given the complexity of what Marsden’s objectives are, combined with his terrible track record over the last 20 years, failure to bring this drug to market in 2 decades, he is not the person who wealthy companies with deep pockets will want to strike a deal with.
Even if Synairgen persuade big pharma to fund a trial for their drug, big pharma will not do this for free.
So how much of the company will be given away?
Furthermore, a fund raise will be necessary anyway to pay the staff wages and hefty salaries of all the new hirings that Marsden made last year and continues to make.
So even if Synairgen do persuade big pharma to help by finding a trial, they will still need their own funding by the end of the year.
They will not have a marketable approved drug by the end of the year, therefore a fund raise of some sort is inevitable now.
There are two scenarios:
1. Unlikely, but a possibility is that Synairgen land their only drug on a free trial. In which case the share price will increase. We could see 70p. This gives the company room at the end of the year to dilute the shares with a new fund raise and bring the price down to the 30’s.
2. Synairgen do not land on a free trial (most biotech developers do not receive free trial invites, particularly ones with such poor records, no approved drugs).
In which case we see the gradual decline in share price to new record lows and then a fund raise simply to help with company operating costs could see a 2p price target for 2024.
I’ll shake ya hands for submitting your wealth to Marsden, but at 2p a punt, scooping up 100k shares and just holding for the gamble is worth a huckleberry.
Target prices of either 30’s, if a new trial is announced and the fund raise comes at the end of the year.
Or 2p without news of a trial.
Drew :-)
You’re a real beauty.
What an incredible asset for Marsden you are.
You have lost 97.5% of your wealth, you have had no news for the last 12 months and your CEO refuses to say a word.
Yet you defend him until the very end.
If that isn’t conviction and respect then I don’t know what is. It is admirable and should have been put to use for your British military instead of a useless company that will soon enough need a fund raise or face bankruptcy.
But rest assured that even in the face of bankruptcy and you losing all your wealth, you will still swear allegiance to Marsden until the end.
Extremely impressive, yet misplaced quality of servitude. Shouldn’t you have directed this level of zealotry towards your late queen? Or to your new king? Or to your military?
MrCosts you are not allowed to speak sense.
The legendary Synairgen Zealots are not phased by losing 97.5% of their wealth. They are not phased by their company having only one failed drug and expensive hirings who have done absolutely nothing in 12 months. They are certainly not phased by no trial updates or anything at all by their CEO in an entire year.
They stand steadfast in allegiance with their CEO Marsden who has failed in the last 20 years.
They are the legendary zealots of the realm of Synairgen. They will defend Marsden from any attacks until the company goes bankrupt at all costs, their servitude and selflessness is entirely noble, they will sacrifice all their wealth to save him.